Metformin is one of the most commonly prescribed medications for the treatment of type 2 diabetes. It's been around for nearly five decades. But what makes it so popular? How long will it be popular? Is it at risk of being replaced? This agent's pharmacological properties are now being lauded for use in a variety of other indications. New aspects of its personality are emerging, piqueing the scientific community's interest in this 'middle-aged molecule'. Join us live with Dr. Sanjay Kalra to learn more about this molecule, also known as the 'Midlife maturity, maiden charm' diabetes drug.

Metformin - Should we stop prescribing it in type 2 DM?

Director, Bharti Research Institute of Diabetes & Endocrinology (BRIDE), Karnal, India | President Elect, South Asian Federation of Endocrine Societies| Past President - Endocrine Society of India|

Dr. Sanjay Kalra

1

1.6k

32.6k

4.8

Sessions Taken

2.7k

4.8